SUNITINIB for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where SUNITINIB was used for Neoplasm.
Most Reported Side Effects for SUNITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 280 | 15.7% | 44 | 36 |
| Drug ineffective | 243 | 13.6% | 50 | 66 |
| Malignant neoplasm progression | 242 | 13.6% | 80 | 32 |
| Fatigue | 132 | 7.4% | 22 | 26 |
| Diarrhoea | 129 | 7.2% | 24 | 38 |
| Osteonecrosis of jaw | 115 | 6.5% | 2 | 8 |
| Hypertension | 99 | 5.6% | 7 | 17 |
| Off label use | 99 | 5.6% | 11 | 20 |
| Thrombocytopenia | 96 | 5.4% | 21 | 35 |
| Death | 85 | 4.8% | 83 | 6 |
| Palmar-plantar erythrodysaesthesia syndrome | 84 | 4.7% | 7 | 13 |
| Neutropenia | 80 | 4.5% | 15 | 15 |
| Gastrointestinal stromal tumour | 75 | 4.2% | 25 | 8 |
| Anaemia | 74 | 4.2% | 10 | 33 |
| Nausea | 69 | 3.9% | 12 | 31 |
Other Indications for SUNITINIB
Gastrointestinal stromal tumour (297)
Metastatic renal cell carcinoma (229)
Product used for unknown indication (202)
Renal cell carcinoma (143)
Clear cell renal cell carcinoma (95)
Renal cancer (80)
Neoplasm malignant (56)
Pancreatic neuroendocrine tumour (37)
Metastases to bone (31)
Pancreatic neuroendocrine tumour metastatic (29)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)